Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 148411-57-8
2. 77224-08-9
3. (2r,3s,4r,5r,6s)-5-amino-6-[(2r,3s,4r,5r,6r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)oxane-3,4-diol
4. 2-amino-4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-2-deoxy-beta-d-glucopyranose
5. B-d-glucopyranose,2-amino-4-o-(2-amino-2-deoxy-b-d-glucopyranosyl)-2-deoxy-
6. (2r,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,4-diol
7. Deacetylated Chitin
8. Poly(d-glucosamine)
9. Schembl186177
10. Chebi:50677
11. Dtxsid80584131
12. Zinc25723126
13. Akos037515792
14. Cs-0239055
15. Chitosan Oligosaccharide Lactate, Average Mn 5,000
16. Q27122179
17. 4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-beta-d-glucosamine
18. Wurcs=2.0/1,2,1/[a2122h-1b_1-5_2*n]/1-1/a4-b1
19. 2-amino-4-o-(2-amino-2-deoxy-
20. A-d-glucopyranosyl)-2-deoxy-
21. A-d-glucopyranose
Molecular Weight | 340.33 g/mol |
---|---|
Molecular Formula | C12H24N2O9 |
XLogP3 | -5.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 4 |
Exact Mass | 340.14818035 g/mol |
Monoisotopic Mass | 340.14818035 g/mol |
Topological Polar Surface Area | 201 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 390 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Undisclosed
Lead Product(s): Chitosan Hydrochloride,Inapplicable
Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Sponsor: Matís ohf | Reykjalundur Rehabilitation Center | Primex ehf
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 16, 2020
Lead Product(s) : Chitosan Hydrochloride,Inapplicable
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Matís ohf | Reykjalundur Rehabilitation Center | Primex ehf
Deal Size : Inapplicable
Deal Type : Inapplicable
MicroFIBERgut: Effects of Lifestyle Changes and Chitosan on Gut Microbiota and Weight Management
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 16, 2020
Details:
Undisclosed
Lead Product(s): Chitosan Hydrochloride,Inapplicable
Therapeutic Area: Gastroenterology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 14, 2018
Lead Product(s) : Chitosan Hydrochloride,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Occult Obscure Gastrointestinal Bleeding
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 14, 2018
Details:
Undisclosed
Lead Product(s): Chitosan Hydrochloride,Inapplicable
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Plant Extract/Herbal
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 23, 2014
Lead Product(s) : Chitosan Hydrochloride,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Medical Chitosan or Sodium Hyaluronate for Knee Osteoarthritis (CHOOSE)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 23, 2014
Details:
Undisclosed
Lead Product(s): Chitosan Hydrochloride,Acetylcysteine
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Plant Extract/Herbal
Sponsor: Croma-Pharma
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 20, 2012
Lead Product(s) : Chitosan Hydrochloride,Acetylcysteine
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Croma-Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 20, 2012
15 Apr 2016
// PHARMA-EXCIPIENTS
http://www.pharma-excipients.ch/2016/04/14/factors-%C4%B1nfluencing-antibacterial-activity-of-chitosan-against-aeromonas-hydrophila-and-staphylococcus-aureus/
17 Feb 2016
// PHARMA-EXCIPIENTS
http://www.pharma-excipients.ch/2016/02/18/formulation-and-development-of-ternary-hybrid-matrix-tablets-of-diltiazem-hydrochloride/
Market Place
Reply
16 Jun 2023
Reply
03 Nov 2020
Reply
30 Jan 2020
Reply
09 Dec 2019
Reply
29 Apr 2025
Reply
27 Jan 2025
ABOUT THIS PAGE
39
PharmaCompass offers a list of Chitosan Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chitosan Hydrochloride manufacturer or Chitosan Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chitosan Hydrochloride manufacturer or Chitosan Hydrochloride supplier.
PharmaCompass also assists you with knowing the Chitosan Hydrochloride API Price utilized in the formulation of products. Chitosan Hydrochloride API Price is not always fixed or binding as the Chitosan Hydrochloride Price is obtained through a variety of data sources. The Chitosan Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chitosan Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chitosan Hydrochloride, including repackagers and relabelers. The FDA regulates Chitosan Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chitosan Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chitosan Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chitosan Hydrochloride supplier is an individual or a company that provides Chitosan Hydrochloride active pharmaceutical ingredient (API) or Chitosan Hydrochloride finished formulations upon request. The Chitosan Hydrochloride suppliers may include Chitosan Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Chitosan Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chitosan Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Chitosan Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Chitosan Hydrochloride DMFs exist exist since differing nations have different regulations, such as Chitosan Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chitosan Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Chitosan Hydrochloride USDMF includes data on Chitosan Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chitosan Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chitosan Hydrochloride suppliers with USDMF on PharmaCompass.
Chitosan Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chitosan Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chitosan Hydrochloride GMP manufacturer or Chitosan Hydrochloride GMP API supplier for your needs.
A Chitosan Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Chitosan Hydrochloride's compliance with Chitosan Hydrochloride specifications and serves as a tool for batch-level quality control.
Chitosan Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Chitosan Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chitosan Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Chitosan Hydrochloride EP), Chitosan Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chitosan Hydrochloride USP).